Stockscreener 앱 받기
15.83
0.51%
0.08
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
Integra LifeSciences to Release First Quarter 2025 Financial Results on May 5, 2025 - Nasdaq
Integra LifeSciences to Host First Quarter 2025 Financial Results Conference Call on May 5, 2025 - Yahoo Finance
Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Truist Adjusts Price Target for Integra LifeSciences (IART) Ahea - GuruFocus
Integra LifeSciences stock hits 52-week low at $16.76 - Investing.com
Integra LifeSciences stock hits 52-week low at $16.76 By Investing.com - Investing.com Canada
Attention Long-Term Shareholders of Axsome Therapeutics, - GlobeNewswire
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Sei Investments Co. - Defense World
Do Options Traders Know Something About Integra (IART) Stock We Don't? - Yahoo Finance
Norges Bank Acquires New Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Alert to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); General Motors Company (NYSE: GM); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and ModivCare, Inc. (NASDAQ: MODV): Act Now as Grabar Law Office Is - GlobeNewswire
Orion Portfolio Solutions LLC Invests $728,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
15,100 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Purchased by KLP Kapitalforvaltning AS - Defense World
Corebridge Financial Inc. Decreases Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Raymond James Financial Inc. Invests $943,000 in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Alert to Long-Term Shareholders of Driven Brands Holdings, - GlobeNewswire
Argus upgrades Integra to Buy, says well-positioned for a turnaround - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Rating Increased to Buy at Argus - Defense World
Argus raises Integra LifeSciences stock rating to buy, sets $28 target By Investing.com - Investing.com South Africa
Argus raises Integra LifeSciences stock rating to buy, sets $28 target - Investing.com
ALERT: Grabar Law Office Investigates Claims for Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra Lifesciences Holdings Corporation (NASDAQ: IART); Kyverna Therapeutics, Inc. (NASDAQ: KYTX); and Virtu Financial, Inc. (NASDAQ: VIRT) - Morningstar
Pediatric Neurology Devices Market Worth, $5.8 Billion by 2031 | - openPR.com
Quantbot Technologies LP Sells 64,470 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
IART INVESTOR REMINDER: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending - ACCESS Newswire
Alert to Long-Term Shareholders of Holley Inc. (NYSE: - GlobeNewswire
Alert to Long-Term Shareholders of Holley Inc. (NYSE: HLLY); Integra LifeSciences Holdings Corporation (NASDAQ: IART); Outset Medical, Inc. (NASDAQ: OM); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Is Investigating Claims on Your Behal - Morningstar
Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
Notice to Long-Term Shareholders of Driven Brands Holdings, - GlobeNewswire
Notice to Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Holley Inc. (NYSE: HLLY); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and Virtu Financial Inc. (NASDAQ: VIRT): Grabar Law Office Is Investigating Claims On Your Behalf - GlobeNewswire Inc.
Notice to Long-Term Shareholders of Akero Therapeutics, - GlobeNewswire
Notice to Long-Term Shareholders of Akero Therapeutics, Inc. (Nasdaq: AKRO); Driven Brands Holdings, Inc. (Nasdaq: DRVN); Integra Lifesciences Holdings Corporation (Nasdaq: IART); and Kyverna Therapeutics, Inc. (Nasdaq: KYTX): Grabar Law Office is I - TradingView
Victory Capital Management Inc. Sells 9,832 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Grabar Law Investigates Integra LifeSciences (IART) Board for Potential Fiduciary Breach Amid Securities Fraud Allegations – Apnakal market - Apna Kal
Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders - Bluefield Daily Telegraph
Notice to Long-Term Integra Lifesciences Holdings - GlobeNewswire
Notice to Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - TradingView
PNC Financial Services Group Inc. Boosts Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Charles Schwab Investment Management Inc. Increases Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Position Lowered by Bank of New York Mellon Corp - Defense World
3 Reasons IART is Risky and 1 Stock to Buy Instead - Yahoo Finance
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Yahoo Finance
Integra LifeSciences Holdings Corp. to Host Earnings Call - ACCESS Newswire
Amalgamated Bank Has $440,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - SETE News
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up - Yahoo Finance
Decoding Integra Lifesciences Holdings Corp (IART): A Strategic SWOT Insight - GuruFocus
Integra LifeSciences (NASDAQ:IART) Trading Up 5.1%Time to Buy? - MarketBeat
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Investor Network: INTEGRA LIFESCIENCES HOLDINGS CORP to Host Earnings Call - ACCESS Newswire
Integra LifeSciences Holdings Corp Releases 2024 Form 10-K Report: A Comprehensive Analysis of Financial Performance, Business Strategy, and Market Challenges - HPBL
Integra LifeSciences maintains $35 target, Market Outperform rating By Investing.com - Investing.com South Africa
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Call Highlights: Strong Revenue ... - Yahoo Finance
INTEGRA LIFESCIENCES HOLDINGS CORP SEC 10-K Report - TradingView
1.01%
0.46%
자본화:
|
볼륨(24시간):